References
- Loehrer P J, Lawrence H. Diagnosis and treatment. Drugs five years later: Cisplatin. Ann Intern Med 1984; 100: 704–13
- Waters G S, Ahmad M, Katsarkas A, Stanimir G, McKay J. Ototoxicity due to cis-diamminedichloroplat-inum in the treatment of ovarian cancer: influence of dosage and schedule of administration. Ear Hearing 1991; 12: 91–102
- Blakley B W, Gupta A K, Myers S F, Schwan S. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 1994; 120: 541–6
- Singh G, Koropatnick J. Differential toxicity of cis and trans isomers of dichlorodiammineplatinum. J Biochem Toxicol 1988; 3: 223–33
- Singh G. A possible cellular mechanism of cisplatin-in-duced nephrotoxicity. Toxicology 1989; 58: 71–80
- Blisard K S, Harrington D A, Long D A, Jackson JE. Relative lack of toxicity of transplatin compared with cisplatin in rodents. J Comp Pathol 1991; 105: 367–75
- Boudvillain M, Dalbies R, Aussourd C, Leng M. Nucleic Acids Res 1995; 13: 2381–8
- Tange R A, Vuzevski VD. Changes in the stria vascularis of the guinea pig due to cis-platinum. Arch Otorhinolar-yngol 1984; 239: 41–7
- Barron S E, Daigneault EA. Effect of cisplatin on hair cell morphology and lateral wall Na,K-ATPase activity. Hearing Res 1987; 26: 131–7
- Kohn S, Fradis M, Pratt H, Zidan J, Podoshin L, Robinson E, Nir I. Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. Laryngoscope 1988; 98: 865–71
- Laurell G, Engstromm B. The ototoxic effect of cisplatin on guinea pigs in relation to dosage. Hearing Res 1989; 38: 27–34
- Saito T, Aran JM. Comparative ototoxicity of cisplatin during acute and chronic treatment. ORL J Oto-Rhino-Lary 1994; 56: 315–20
- Komune S, Matsuda K, Nakagawa T, Kimitsuki T, Hisashi K, Inokuchi A, Komiyama S, Kobayashi T. Disturbance of regulation of sodium by cis-di-amminedichloroplatinum in perilymph of the guinea pig cochlea. Ann Oto Rhinol Laryn 1995; 104: 149–54
- Brabec V, Leng M. DNA interstrand cross-links of trans-diamminedichloroplatinum (II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci USA 1993; 90: 5345–9
- Eastman A, Barry MA. Interaction of trans-diamminedichloroplatinum (II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry 1987; 26: 3303–7
- Kelland L R, Barnard C FJ, Mellish K J, Jones M, God-Dard P M, Velenti M, et al. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. Cancer Res 1994; 54: 5618–22
- Attardi G. Biogenesis of mitochondria. Ann Rev Cell Biol 1988; 4: 289–333
- Andrews P A, Albright KD. Mitochondrial defects in cis-diamminedichloroplatinum (Il)-resistant human ovarian carcinoma cells. Cancer Res 1992; 52: 1895–901
- Daoud S S, Clements M K, Small CL. Polymerase chain reaction analysis of cisplatin-induced mitochondrial DNA damage in human ovarian carcinoma cells. Anti-Cancer Drug 1995; 6: 405–12
- Saito T, Aran JM. X-ray microanalysis and ion microscopy of guinea pig cochlea and kidney after cisplatin treatment. ORL J Oto-Rhino-Lary 1994; 56: 310–4
- Saito T, Moataz R, Dulon D. Cisplatin blocks depolarization-induced calcium entry in isolated cochlear outer hair cells. Hearing Res 1991; 56: 143–7
- Yamamoto T, Kakehata S, Saito T, Saito H, Akaike N. Cisplatin blocks voltage-dependent calcium current in dissociated outer hair cells of guinea-pig cochlea. Brain Res 1994; 648: 296–8
- Saito T, Yamamoto T, Zhang Z J, Yamada T, Manabe Y, Saito H. Transplatin blocks voltage-dependent calcium current in isolated cochlear outer hair cells but not ototoxic in vivo. Brain Res 1995; 697: 276–9
- Saito T, Yamada T, Manabe Y, Yamamoto T, Saito H. Cisplatin metabolites and their toxicity on isolated outer hair cells in vitro. Acta Otolaryngol 1996; 116: 561–5